208 related articles for article (PubMed ID: 23247865)
1. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
Kato M; Nakayama M; Agata M; Yoshida K
Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
[TBL] [Abstract][Full Text] [Related]
2. In vivo stoichiometry of shelterin components.
Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
4. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
5. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
6. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
7. TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.
Zimmermann M; Kibe T; Kabir S; de Lange T
Genes Dev; 2014 Nov; 28(22):2477-91. PubMed ID: 25344324
[TBL] [Abstract][Full Text] [Related]
8. Developmental studies of Xenopus shelterin complexes: the message to reset telomere length is already present in the egg.
Vizlin-Hodzic D; Ryme J; Simonsson S; Simonsson T
FASEB J; 2009 Aug; 23(8):2587-94. PubMed ID: 19329760
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
10. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex.
Ye JZ; Hockemeyer D; Krutchinsky AN; Loayza D; Hooper SM; Chait BT; de Lange T
Genes Dev; 2004 Jul; 18(14):1649-54. PubMed ID: 15231715
[TBL] [Abstract][Full Text] [Related]
11. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
12. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
13. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
14. Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.
Zhou JG; Qing YF; Yang QB; Xie WG; Zhao MC
Lupus; 2011 Jul; 20(8):820-8. PubMed ID: 21693493
[TBL] [Abstract][Full Text] [Related]
15. The evolution of metazoan shelterin.
Myler LR; Kinzig CG; Sasi NK; Zakusilo G; Cai SW; de Lange T
Genes Dev; 2021 Dec; 35(23-24):1625-1641. PubMed ID: 34764137
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
18. Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells.
Li P; Hou M; Lou F; Björkholm M; Xu D
Int J Biochem Cell Biol; 2012 Sep; 44(9):1531-40. PubMed ID: 22728163
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of in vivo TRF1 binding to chromatin restricts its location exclusively to telomeric repeats.
Garrobo I; Marión RM; Domínguez O; Pisano DG; Blasco MA
Cell Cycle; 2014; 13(23):3742-9. PubMed ID: 25483083
[TBL] [Abstract][Full Text] [Related]
20. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
